Barbara D. Alexander, M.D., MHS, FIDSA – President, Infectious Diseases Society of America on today’s Pfizer/BioNTech application for Emergency Use Authorization of its COVID-19 vaccine candidate
With numbers of infections, illnesses, hospitalizations and deaths caused by COVID-19 at record highs as this holiday season begins, the risks posed by the spread of the coronavirus are more dangerous than at any time since its emergence last December.
We share and appreciate the urgency in expanding therapeutic options for COVID-19 as daily case counts and hospitalization rates reach record levels. For new therapeutics to be used widely and routinely outside of clinical trials, we urge that there be sufficient safety and efficacy data to be confident regarding their use.
The Senate Appropriations Committee’s funding proposal for FY2021 makes critical investments in the Ending the HIV Epidemic initiative and NIH but fails to include COVID-19 relief funding.
The Infectious Diseases Society of America and its HIV Medicine Association have reached out today to President-elect Joe Biden to congratulate him and to offer their memberships’ expertise as the new administration takes on the challenges of the COVID-19 pandemic and other infectious diseases threats.
New guidance published today by an expert panel of the HIV Medicine Association of the Infectious Diseases Society of America updates the 2013 guideline for providing comprehensive evidence-based primary care to people with HIV.
The Infectious Diseases Society of America, HIV Medicine Association, Pediatric Diseases Society and the Society of Healthcare Epidemiology of America have called on the Department of Homeland Security to exempt physicians working in the United States on J-1 visas from the agency’s proposed rule
"In September the Trump Administration released an “Executive Order on Combating Race and Sex Stereotyping,” which would allow federal agencies to terminate contracts intended to help promote study and understanding of diversity, equity and inclusion across government institutions."
A paper jointly published in Clinical Infectious Diseases and the Journal of Pediatric Infectious Diseases describes how the frontline experiences and perspectives of infectious diseases and HIV health care professionals have made pivotal differences to critical public health responses, from informing domestic and global efforts to prevent and contain pandemics
The executive order signed last week that strips protections from our nation’s civil service workforce comes at a time when the critical role of career staff in guiding federal responses to public health needs could not be more clear.
New research from a team of experts in Chicago shows a significant increase in the number of patients with acute HIV infections who sought treatment in their emergency department, possibly out of a fear of COVID-19, according to a study being presented at IDWeek 2020. Routine tests for HIV went down during this period.
The authorization or licensure of a COVID-19 vaccine must include the highest standards of thorough and transparent review to ensure the safety and effectiveness as well as the acceptance and uptake of an immunization against the novel coronavirus.